Presentation Agenda

• Opening remarks

  • Leslie L. Shelly, Ph.D. - Associate Director, Regulatory Affairs*

• Scientific and medical summary of Zevalin

  • Christine A. White, M.D. - Vice President, Medical Affairs*

• Discussion

  • Christine A. White, M.D. - Vice President, Medical Affairs*
  • Pratik Multani, M.D. - Director, Medical Affairs*
  • Bryan Leigh, M.D. - Director, Oncology*

*IDEC Pharmaceuticals, San Diego, CA

Previous slide

Next slide

Back to first slide

View graphic version